Vivo Bio Tech Ltd

Ticker: VIVOBIOT
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
37.08
Market Cap
81.95
Debt/Equity
0.6936
ROE %
10.990
PB
1.0520
Promoter %
36.429
Pledge %
0.000
1Y Rev Growth %
13.146
5Y Rev Growth %
-1.461
NP Margin %
14.125
NP Margin 5Y Avg %
7.996

Trading Reference

1M Return %
-0.700
6M Return %
3.924
1Y Return %
0.816
% Away 52W High
53.452
% Away 52W Low
18.846
Daily Volume
14903
Investment Verdict
Hold
Score 67/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 15/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Vivo Bio Tech Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a potential for upward movement. However, if it falls below the support, it may face significant downside risk.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Vivo Bio Tech Ltd is a leading biotechnology company in India, focused on innovative research and development in the life sciences sector. Catering to pharmaceutical, agricultural, and healthcare industries, it plays a crucial role in enhancing quality of life through advanced biotechnological solutions. With a commitment to sustainable practices and cutting-edge technology, Vivo Bio Tech is poised for significant growth and impact.

  • Leading player in India's biotech industry
  • Focus on pharmaceuticals, agriculture, and healthcare
  • Innovative research and development
  • Commitment to sustainable practices
  • Strong potential for growth and impact

Investment Thesis

Vivo Bio Tech Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a noteworthy consideration for retail investors seeking long-term gains.

  • Strong promoter group with a proven track record in the biotech sector.
  • Expanding digital services segment poised for substantial growth.
  • Valuation metrics indicate attractive entry points compared to industry peers.
  • Commitment to innovation and R&D enhances competitive advantage.
  • Favorable market conditions support future revenue growth.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech solutions
  • Strong R&D pipeline
  • Potential for strategic partnerships
  • Expanding international markets
Risks ⚠️
  • Regulatory challenges
  • High competition in biotech
  • Dependence on key personnel
  • Market volatility impacts

Peer Perspective

Vivo Bio Tech Ltd trades at a discount compared to peers like Biocon and Dr. Reddy's, primarily due to its lower growth rate; a rerating could occur with improved margin stability and enhanced revenue growth.

Future Outlook

Vivo Bio Tech Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities; however, successful execution and effective cost control will be critical to achieving its long-term potential.

AI FAQs for Retail Users

  • Q: What does Vivo Bio Tech Ltd do?
    A: Vivo Bio Tech Ltd specializes in biotechnology, focusing on research and development in life sciences.
  • Q: Is Vivo Bio Tech Ltd profitable?
    A: Profitability can vary; it's important to review recent financial reports for the latest performance.
  • Q: What are the risks of investing in Vivo Bio Tech Ltd?
    A: Risks include market volatility, regulatory changes, and sector-specific challenges in biotechnology.
  • Q: How can I buy shares of Vivo Bio Tech Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: Where can I find more information about Vivo Bio Tech Ltd?
    A: Check the company's official website, stock exchange filings, and financial news sources for updates.
📊 Stock Investment Checklist (100 Points)
Vivo Bio Tech Ltd • Updated: 2025-09-18 08:46:36
  • 8
    Business
    High
    The biotech sector has potential but faces regulatory challenges.
  • 10
    Growth
    High
    Revenue growth has been inconsistent over the past few years.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages.
  • 9
    Valuation
    High
    Valuation metrics indicate overvaluation compared to peers.
  • 6
    Balance
    Good
    Moderate debt levels with limited liquidity.
  • 7
    Governance
    High
    Promoter holding is decent but there are concerns about disclosures.
  • 5
    Drivers
    Good
    Limited growth drivers identified, execution risks are high.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Vivo Bio Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.


More Like This